Extracellular histones indicate the prognosis in patients undergoing extracorporeal membrane oxygenation therapy.

Extracellular histones are known contributors to cell damage and organ injury. Our study showed that extracellular histones have a predictive value in the assessment of outcome of patients undergoing ECMO therapy and may be helpful for risk stratification in clinical settings.